Celecoxib:Nicotinamide dissociation:: Using excipients to capture the cocrystal's potential

被引:149
作者
Remenar, Julius F.
Peterson, Matthew L.
Stephens, Peter W.
Zhang, Zhong
Zimenkov, Yuri
Hickey, Magali B.
机构
[1] TransForm Pharmaceut Inc, Lexington, MA 02421 USA
[2] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA
关键词
polymorphs; pharmaceutical; cocrystal; nicotinamide; morphology; dissolution; stability; celecoxib; formulation;
D O I
10.1021/mp0700108
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The cocrystal of celecoxib and nicotinamide ( Cel: Nic) was crystallized from chloroform in a 1: 1 ratio, and the structure has been solved from powder X- ray diffraction data. The dissolution and solubility of Cel: Nic are medium dependent and can be attributed to differences in conversion of Cel: Nic to celecoxib polymorphs I and III (Cel- I and CeI-III). The presence of low concentrations of surfactants facilitates the rapid conversion of neat Cel: Nic to large aggregates of Cel- III that dissolve more slowly than commercial Cel- III into 1% SDS solution. In contrast, combinations of CeI: Nic with both 1-10% solid SDS and PVP wet rapidly and convert to a mixture of amorphous celecoxib and a micron-sized crystalline celecoxib form IV (CeI- IV), which has recently been shown to be up to 4-fold more bioavailable than marketed CeI-III. More than 90% of the suspended material dissolves within 2 min at 37 degrees C when transferred to 1% SDS solution. This example highlights the importance of exploring the form conversion of cocrystals in aqueous media prior to pharmacokinetic studies, and illustrates the potential of simple formulations to overcome the limitations caused by rapid dissociation of cocrystals and recrystallization of poorly soluble forms in aqueous media.
引用
收藏
页码:386 / 400
页数:15
相关论文
共 42 条
[1]   Crystal engineering of the composition of pharmaceutical phases.: Do pharmaceutical co-crystals represent a new path to improved medicines? [J].
Almarsson, Ö ;
Zaworotko, MJ .
CHEMICAL COMMUNICATIONS, 2004, (17) :1889-1896
[2]   PATTERNS IN HYDROGEN BONDING - FUNCTIONALITY AND GRAPH SET ANALYSIS IN CRYSTALS [J].
BERNSTEIN, J ;
DAVIS, RE ;
SHIMONI, L ;
CHANG, NL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1995, 34 (15) :1555-1573
[3]   EFFECT OF COMPLEXATION WITH PHENOBARBITAL ON BIOLOGIC AVAILABILITY OF THEOPHYLLINE FROM 3 TABLET FORMULATIONS [J].
BETTIS, JW ;
LACH, JL ;
HOOD, J .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1973, 30 (03) :240-243
[4]  
BRUKER AXS, 2005, GEN PROFILE STRUCTUR
[5]   Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids [J].
Childs, SL ;
Chyall, LJ ;
Dunlap, JT ;
Smolenskaya, VN ;
Stahly, BC ;
Stahly, GP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (41) :13335-13342
[6]   Indexing of powder diffraction patterns by iterative use of singular value decomposition [J].
Coelho, AA .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2003, 36 :86-95
[7]  
DEV VR, 1999, ACTA CRYSTALLOGR C, V55
[8]   HYDROGEN-BOND DIRECTED COCRYSTALLIZATION AND MOLECULAR RECOGNITION PROPERTIES OF DIARYLUREAS [J].
ETTER, MC ;
URBANCZYKLIPKOWSKA, Z ;
ZIAEBRAHIMI, M ;
PANUNTO, TW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (23) :8415-8426
[9]   GRAPH-SET ANALYSIS OF HYDROGEN-BOND PATTERNS IN ORGANIC-CRYSTALS [J].
ETTER, MC ;
MACDONALD, JC ;
BERNSTEIN, J .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 1990, 46 :256-262
[10]  
FERRO LJ, 2000, INT PUBLICATION NUMB